Get the Stockscreener App
2.37
17.91%
0.36
After Hours:
2.30
-0.07
-2.95%
Anebulo Pharmaceuticals Inc stock is traded at $2.37, with a volume of 993.52K.
It is up +17.91% in the last 24 hours and down -0.42% over the past month.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
See More
Previous Close:
$2.01
Open:
$2.36
24h Volume:
993.52K
Relative Volume:
8.01
Market Cap:
$97.37M
Revenue:
-
Net Income/Loss:
$-7.92M
P/E Ratio:
-7.90
EPS:
-0.3
Net Cash Flow:
$-7.05M
1W Performance:
-0.42%
1M Performance:
-0.42%
6M Performance:
+71.74%
1Y Performance:
+13.40%
1-Day Range:
$2.32
$2.5799
1-Week Range:
$1.77
$2.5799
52-Week Range:
$0.8001
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Name
Anebulo Pharmaceuticals Inc
Sector
Industry
Phone
737 203 5270
Address
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Compare ANEB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.37 | 84.63M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News
Anebulo Pharmaceuticals reviews strategic alternatives amid going private plan - Investing.com
Technical signs of recovery in Anebulo Pharmaceuticals Inc.2025 Year in Review & Real-Time Buy Zone Alerts - Newser
Using Python tools to backtest Anebulo Pharmaceuticals Inc. strategiesWeekly Investment Report & Growth Oriented Trading Recommendations - Newser
Anebulo Pharmaceuticals Explores Strategic Alternatives Update - MSN
Can momentum traders help lift Anebulo Pharmaceuticals Inc.July 2025 Short Interest & AI Based Buy and Sell Signals - Newser
Anebulo Pharmaceuticals announces update on going private transaction and strategic alternatives - MarketScreener
Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives - Business Wire
Does Anebulo Pharmaceuticals Inc. show high probability of reboundMarket Sentiment Review & Verified Momentum Watchlists - Newser
Identifying reversal signals in Anebulo Pharmaceuticals Inc.Weekly Volume Report & Risk Managed Investment Strategies - Newser
Using data tools to time your Anebulo Pharmaceuticals Inc. exitQuarterly Trade Report & Expert Approved Momentum Ideas - Newser
Exit strategy if you’re trapped in Anebulo Pharmaceuticals Inc.Quarterly Growth Report & Weekly High Return Opportunities - Newser
Order flow analysis tools used on Anebulo Pharmaceuticals Inc.2025 Winners & Losers & High Accuracy Trade Alerts - Newser
Will a bounce in Anebulo Pharmaceuticals Inc. offer an exit2025 Technical Patterns & Reliable Price Action Trade Plans - Newser
Market reaction to Anebulo Pharmaceuticals Inc.’s recent newsBear Alert & Risk Controlled Daily Plans - Newser
Developing predictive dashboards with Anebulo Pharmaceuticals Inc. data2025 Trade Ideas & Free Accurate Trade Setup Notifications - Newser
Anebulo Pharmaceuticals Inc. stock outlook for YEARWeekly Trade Review & Expert Verified Stock Movement Alerts - Newser
Will Anebulo Pharmaceuticals Inc. rebound enough to break evenWeekly Trade Review & Daily Chart Pattern Signals - Newser
How to interpret RSI for Anebulo Pharmaceuticals Inc. stockJuly 2025 Intraday Action & Verified Swing Trading Watchlists - Newser
Smart tools for monitoring Anebulo Pharmaceuticals Inc.’s price actionJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - Newser
Is Anebulo Pharmaceuticals Inc. stock bottoming outJuly 2025 Action & Smart Allocation Stock Tips - Newser
Using economic indicators to assess Anebulo Pharmaceuticals Inc. potentialWeekly Trade Summary & Daily Chart Pattern Signals - Newser
Should you hold or exit Anebulo Pharmaceuticals Inc. now2025 Price Targets & Free Long-Term Investment Growth Plans - Newser
Using portfolio simulators with Anebulo Pharmaceuticals Inc. included2025 EndofYear Setup & Weekly Market Pulse Alerts - Newser
Should you wait for a breakout in Anebulo Pharmaceuticals Inc.July 2025 Trade Ideas & Daily Technical Forecast Reports - Newser
Is Anebulo Pharmaceuticals Inc. a good ESG investmentWeekly Trade Review & AI Driven Stock Movement Reports - Lancaster City Council
Will Anebulo Pharmaceuticals Inc. see short term momentumWeekly Stock Analysis & Verified Chart Pattern Signals - Newser
Is Anebulo Pharmaceuticals Inc. gaining market share2025 Market WrapUp & Risk Controlled Swing Alerts - Lancaster City Council
Tools to monitor Anebulo Pharmaceuticals Inc. recovery probabilityJuly 2025 Sector Moves & High Win Rate Trade Tips - Newser
Can Traders Expect Breakout From Anebulo Pharmaceuticals Inc. This Week2025 Price Targets & Daily Stock Trend Watchlist - beatles.ru
Is Anebulo Pharmaceuticals Inc. stock poised for growthJuly 2025 Sector Moves & Stepwise Trade Execution Plans - Newser
Anebulo Pharmaceuticals Inc Stock (ANEB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):